Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-29
2007-05-29
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253120, C544S121000, C544S365000
Reexamination Certificate
active
11289834
ABSTRACT:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.
REFERENCES:
patent: 5650415 (1997-07-01), Tang et al.
patent: 6069143 (2000-05-01), Ali et al.
patent: 6099851 (2000-08-01), Weisman et al.
patent: 0 385 850 (2000-09-01), None
patent: WO 99/60023 (1999-11-01), None
patent: WO 00/02871 (2000-01-01), None
patent: WO 00/08202 (2000-02-01), None
patent: WO 00/12089 (2000-03-01), None
patent: WO 00/17203 (2000-03-01), None
patent: WO 00/20023 (2000-04-01), None
patent: WO 00/23469 (2000-04-01), None
patent: WO 00/35455 (2000-06-01), None
patent: WO 00/53605 (2000-09-01), None
patent: WO 01/17995 (2001-03-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/72751 (2001-10-01), None
Ali et al., STN International, HCAPLUS Database, Accession No. 2000:17476, Reg. No. 193902-45-3 (2007).
Parrizas, et al. (1997) Endocrinology 138: 1427-1433.
Blum, et al. (2000) Biochemistry 39:15705-15712.
Gungor, et al. (1992( J. Med. Chem. 35:4455-4463.
Chimirri et al., Heterocycles, vol. 53, No. 3, pp. 613-620, 2000.
Nawwar et al., Chemical Abstract No. 164052r, vol. 120, No. 13, Mar. 28, 1994.
Pednekar et al., Chemical Abstract No. 182731b, vol. 96, No. 22, May 31, 1982.
Sahal, et al. (1988) Archives of Biochemistry and Biophysics 260:416-426.
Balasubramanian Neelakantan
Frennesson David B.
Liu Peiying
Marinier Anne
Roy Stephan
Bristol--Myers Squibb Company
Freistein Andrew B.
Korsen Elliott
McKane Joseph K.
LandOfFree
Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3775025